Answers are grounded in this paper and cite their sources.
Clinical case reports alopecia due to follicular involvement by multicentric reticulohistiocytosis, indicating a novel link.
Multicentric reticulohistiocytosis (MRH) is a systemic inflammatory disease with dermatologic, musculoskeletal, and mucosal manifestations with symmetric erosive arthritis and reddish-brown papulonodular lesions. Histopathologic findings include epithelioid and multinucleated histiocytes with ground glass cytoplasm. We demonstrate the case of a 52-year-old female who presented with scattered red-brown papules, finger swelling, and muscle pain. Biopsy demonstrated a dermal proliferation of large mononucleated and multinucleated histiocytes with dense, pink, oncocytic cytoplasm, consistent with MRH. Patient initiated prednisone, methotrexate, folic acid, and adalimumab. On follow-up, the patient reported progressive hair loss confined to the frontal scalp. Physical exam showed moderately well-defined, pauci-inflammatory alopecic patches with follicular drop-out and negative hair pull test. A punch biopsy from the scalp demonstrated a marked decrease in follicular units associated with aggregates of histiocytes in the upper dermis with infiltration of the follicular epithelium, some multinucleate, with abundant two-toned ground-glass cytoplasm. A diagnosis of alopecia secondary to follicular involvement by reticulohistiocytosis was made. To our knowledge, this is the first reported case of alopecia secondary to MRH in the literature.
No takes yet. Share an insight, caveat, or question.
Zimbric et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: